caa a22 4500 469064064 CHVBK 20180323132903.0 cr unu---uuuuu 170328e19920301xx s 000 0 eng 10.1007/BF02914376 doi (NATIONALLICENCE)springer-10.1007/BF02914376 Asthma [Elektronische Daten] A role for IVIG therapy? [Philip Fireman, Gilbert Friday] Asthma is a multifactorial, reversible, obstructive lung disease that manifests airway inflammation as well as airway hyperreactivity. In addition to IgE-mediated respiratory reactions, the pathophysiology of asthma can be triggered by both viral respiratory and bacterial sinopulmonary infections. Even though most asthma patients do not manifest undue susceptibility to infection, a subset of asthma patients with recurrent sinopulmonary as well as upperrespiratory infections may have an associated immune deficiency syndrome. In a subset of these patients, deficiencies of serum IgG subclasses have also been described in the presence of low-normal or normal serum IgG and also deficient serum IgA. In addition to the usual asthma therapy with β2 agonist and theophylline bronchodilators as well as cromolyn and steroids, many of these immunodeficiency patients will benefit from iv γ-globulin therapy. However, we suggest that an inability to synthesize specific serum antibody to injected vaccines or immunogens be a prerequisite before initiating iv γ-globulin therapy. The clinician should not rely on serum IgG subclass levels alone as a criterion for initiation of passive immune globulin therapy. There may be another cohort of asthma patients who could benefit from iv γ-globulin therapy. In a small open-label pilot study severe steroid-dependent asthma patients who were not immunodeficient and did not have undue susceptibility to infection were treated with iv γ-globulin with a very large dosage protocol of 2000 mg/kg monthly. These patients' asthms symptoms improved, their pulmonary functions improved, and they were able to reduce their steropd medication. The Humana Press Inc, 1992 Fireman Philip School of Medicine, Children's Hospital of Pittsburgh, The University of Pittsburgh, PA aut Friday Gilbert School of Medicine, Children's Hospital of Pittsburgh, The University of Pittsburgh, PA aut Clinical Reviews in Allergy Humana Press 10/1-2(1992-03-01), 135-142 0731-8235 10:1-2<135 1992 10 12016 https://doi.org/10.1007/BF02914376 text/html Onlinezugriff via DOI 1 research-article jats NATIONALLICENCE 856 40 https://doi.org/10.1007/BF02914376 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Fireman Philip School of Medicine, Children's Hospital of Pittsburgh, The University of Pittsburgh, PA aut NATIONALLICENCE 700 1- Friday Gilbert School of Medicine, Children's Hospital of Pittsburgh, The University of Pittsburgh, PA aut NATIONALLICENCE 773 0- Clinical Reviews in Allergy Humana Press 10/1-2(1992-03-01), 135-142 0731-8235 10:1-2<135 1992 10 12016 Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer